
Hygea Medical Technology Co., Ltd., founded in 2010 and headquartered in Beijing, is a national high-tech enterprise integrating research, production, and sales, focusing on minimally invasive tumor interventional therapy. Its flagship product, Kangbo Knife®, broke the dependence on imported tumor minimally invasive devices and leads the combined cold and heat ablation industry. The company has achieved EU CE certification, FDA breakthrough device recognition, and multiple international awards. It launched Beijing's first microwave ablation device in 2023, which gained FDA approval in 2024. Hygea operates a tumor minimally invasive innovation center and holds over 200 domestic and international intellectual property rights. It aims to build an innovative medical device platform for minimally invasive treatment, serving over 10,000 patients and covering more than 30 provinces in China.

Hygea Medical Technology Co., Ltd., founded in 2010 and headquartered in Beijing, is a national high-tech enterprise integrating research, production, and sales, focusing on minimally invasive tumor interventional therapy. Its flagship product, Kangbo Knife®, broke the dependence on imported tumor minimally invasive devices and leads the combined cold and heat ablation industry. The company has achieved EU CE certification, FDA breakthrough device recognition, and multiple international awards. It launched Beijing's first microwave ablation device in 2023, which gained FDA approval in 2024. Hygea operates a tumor minimally invasive innovation center and holds over 200 domestic and international intellectual property rights. It aims to build an innovative medical device platform for minimally invasive treatment, serving over 10,000 patients and covering more than 30 provinces in China.